These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6875 related articles for article (PubMed ID: 2705687)

  • 1. Isolated regional perfusion for treatment of limb melanoma in the American black.
    Muchmore JH; Krementz ET; Carter RD; Sutherland CM; Cieutat EG
    Am Surg; 1989 Apr; 55(4):232-7. PubMed ID: 2705687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional perfusion for the treatment of subungual melanoma.
    Muchmore JH; Krementz ET; Carter RD; Sutherland CM; Godfrey RS
    Am Surg; 1990 Feb; 56(2):114-8. PubMed ID: 2306053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy by regional perfusion for limb melanoma.
    Krementz ET; Carter RD; Sutherland CM; Muchmore JH
    Am Surg; 1987 Mar; 53(3):133-40. PubMed ID: 3103506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperthermic isolated limb perfusion (HILP) in malignant melanoma. Experience with 101 patients.
    Knorr C; Meyer T; Janssen T; Goehl J; Hohenberger W
    Eur J Surg Oncol; 2006 Mar; 32(2):224-7. PubMed ID: 16289716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases.
    Deroose JP; Grünhagen DJ; van Geel AN; de Wilt JH; Eggermont AM; Verhoef C
    Br J Surg; 2011 Nov; 98(11):1573-80. PubMed ID: 21739427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surgical treatment and regional chemotherapy in melanoma of the extremities].
    Henneking K; Binder J; Weyers W; Schwemmle K
    Chirurg; 1993 Feb; 64(2):134-8. PubMed ID: 8462350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion.
    Sutherland CM; Mather FJ; Krementz ET
    Surg Gynecol Obstet; 1987 Feb; 164(2):111-8. PubMed ID: 3810424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant regional isolated perfusion with melphalan for patients with Clark V melanoma of the extremities.
    Vrouenraets BC; Kroon BB; Klaase JM; Van Geel BN; Eggermont AM; Franklin HR
    J Surg Oncol; 1993 Apr; 52(4):249-54. PubMed ID: 8468989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free-flap evolution after hyperthermic regional chemotherapy in the isolated limb for malignant melanoma.
    Goldschmidt D; Van Geertruyden J; de Fontaine S
    J Reconstr Microsurg; 1998 Aug; 14(6):397-9. PubMed ID: 9734842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-centre prospective study of isolated limb perfusion with melphalan in the treatment of subungual malignant melanoma.
    Lingam MK; McKay AJ; Mackie RM; Aitchison T
    Br J Surg; 1995 Oct; 82(10):1343-5. PubMed ID: 7489159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival rates of patients with acral lentiginous melanoma treated with hyperthermic isolation perfusion, wide excision, and regional lymphadenectomy.
    Fletcher JR; White CR; Fletcher WS
    Am J Surg; 1986 May; 151(5):593-8. PubMed ID: 3518512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients.
    Kroon HM; Moncrieff M; Kam PC; Thompson JF
    Ann Surg Oncol; 2009 May; 16(5):1184-92. PubMed ID: 19224289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional isolated perfusion with melphalan for patients with subungual melanoma.
    Vrouenraets BC; Kroon BB; Klaase JM; van Geel BN; Eggermont AM; Mooi WJ; van Dongen JA
    Eur J Surg Oncol; 1993 Feb; 19(1):37-42. PubMed ID: 8436239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes following isolated limb infusion for melanoma. A 14-year experience.
    Kroon HM; Moncrieff M; Kam PC; Thompson JF
    Ann Surg Oncol; 2008 Nov; 15(11):3003-13. PubMed ID: 18509706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated limb perfusion with melphalan in the treatment of malignant melanoma.
    Bulman AS; Jamieson CW
    Br J Surg; 1980 Sep; 67(9):660-2. PubMed ID: 7427069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593.
    Koops HS; Vaglini M; Suciu S; Kroon BB; Thompson JF; Göhl J; Eggermont AM; Di Filippo F; Krementz ET; Ruiter D; Lejeune FJ
    J Clin Oncol; 1998 Sep; 16(9):2906-12. PubMed ID: 9738557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated perfusion of extremities for metastatic melanoma from an unknown primary lesion.
    Muchmore JH; Krementz ET; Carter RD; Sutherland CM; Mendoza EA
    South Med J; 1986 Mar; 79(3):288-90. PubMed ID: 3952537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acral lentiginous melanoma.
    Sutherland CM; Mather FJ; Muchmore JH; Carter RD; Reed RJ; Krementz ET
    Am J Surg; 1993 Jul; 166(1):64-7. PubMed ID: 8328633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan.
    Klaase JM; Kroon BB; van Geel AN; Eggermont AM; Franklin HR; Hart AA
    Surgery; 1994 Jan; 115(1):39-45. PubMed ID: 8284759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for survival after isolated limb perfusion for malignant melanoma.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB
    Eur J Surg Oncol; 2003 Dec; 29(10):916-21. PubMed ID: 14624788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 344.